Ceapro Inc V.CZO

At this important time: Blue sky breakout alert

[fossi_2002]

Proph... 14.8.2022

Only about 2 months or 3,33% of the last five years has been higher than $.76. CZO is essentially on the cusp of a five year breakout. As it heads into new territory the market could start chasing dreams.
Canadian pharma icon Ronnie Miller said this was an important time. The next 18 months may be the most important in CZO´s history in terms of market cap added. Here is $5.35 per share in potential dreams the market could start chasing as the stock breaks out into blue sky and over the next 18 months:

$1 per share for the base business.

$1.85 per share for the completion of the PGX-YBG scale-up to 50l. The 40 million dose plant had a NPV of $100 million or $1.25 per shares at 10L. $1.85 per share is about $ 150 million.

$1.00 per share for the completion of preclinical work for fibrosis. Avalyn raised -C$80 million in cash in 2017 preclinically and CZO has COVID and broader fibrotic opportunities.

$1.00 per share for the licensing of PGX/CoQ10 and broader PGX applications.

$0.50 per share for avenanthramide.

Any questions?

[prophetoffactz]

"The next 18 months may be the most important in CZO´s history in terms of market cap added." It's been just that! You should be complementing me! I've long talked about the risk of delays, fossi. You know that very well. We've also went through the worst biotech bear market in history. All of the programs in that post have advanced. PGX is now in the home stretch to